Skip to content
DraconiticResearch
Search Sources API
210,049 studies31 sourcesUpdated 29 min ago

Oncology

5,302 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,302 studies

  1. Biomarker-driven and gene-enhanced viral therapy for malignant peripheral nerve sheath tumor
    M. Saxena, L. Li, B. G. Strittmatter +15
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  2. Dysregulation of epithelial differentiation architecture underlies field cancerization in head and neck cancer
    Claire Mills, Yin Huang, Chan Mi Lee +22
    bioRxivPreprintCC BYFull textOncologybioRxivEurope PMCPMC
  3. A multimodal precision oncology platform integrating genomics,single-cell transcriptomics, and functional drug screening expandstherapeutic options in pediatric brain tumors
    Xiaomeng Huang, Yi Qiao, Gage S. Black +16
    bioRxivPreprintCC BYFull textOncologybioRxivPMC
  4. Catabolism of extracellular glutathione is a driver of metastasis formation
    F. C. Vogel, F. Roehrig, D. Schilling +20
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. Tumour-derived factors prime microglia for immune checkpoint-mediated T-cell regulation
    L. D. Schreurs, J. Barz, T.-H. Nguyen +12
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  6. An RFX-driven ciliogenic cell state defines ex vivo FGFR-inhibitor sensitivity in colorectal cancer
    L. Kralickova, N. Miglino, C. Esposito +13
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  7. Spatial transcriptomics reveals interferon pathway enrichment in early relapsing serous carcinoma
    F. Niemeyer, N. Aho, S. Hanninen +4
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  8. Effects of Immersive Virtual Reality and Relaxation Video on Symptom Severity, Distress, and Quality of Life in Lung Cancer Patients During Initial Chemotherapy Cycles: A Three-Arm Randomised Controlled Trial.
    Kadir Baysoy, Nur Izgu, Leyla Ozdemir +3
    Healthcare (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  9. Triple Genetic Alterations (EGFR Mutation, ALK Fusion, and MET Polysomy) in Gynecological Metastasis of Lung Adenocarcinoma Patient with Acquired Resistance to Furmonertinib: A Case Report.
    Qinglong Jiang, Rui Sun, Haiyan Xu +1
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  10. Latent Profiles of Decision Regret and Associated Factors Among Patients Undergoing Medium- and Long-Term Vascular Access Device Placement in Medical Oncology: A Cross-Sectional Study.
    Xiaoyu Guo, Bo Zheng, Qiang Liu +4
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  11. Copper complexes in the triple-negative breast cancer landscape: advances and opportunities.
    Paula Marynella Alves Pereira Lima, André Carlos Pereira de Matos, Gabriela da Silva Guimarães +2
    Frontiers in molecular biosciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  12. Lysine lactylation in glioma: from metabolic stress to epigenetic remodeling and therapeutic resistance.
    Xiaosong Hu, Li Yang, Yanghao Hu +1
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textOncologyEurope PMC
  13. CD73 targeted combination therapy reverses PD-1 inhibitor resistance in CD73-high PD-L1-negative NSCLC: Evidence from pleural effusion organoids.
    Zi-Rui Ren, Lv Wu, Qian-Lin Huang +11
    Global medical geneticsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  14. Intradural cauda equina hemangioblastomas: Surgical management and long-term outcomes at a von Hippel-Lindau referral center.
    Roberto Doria-Medina, Nicolas Neidert, Marc Hohenhaus +6
    Brain & spinePeer-reviewedCC BYFull textOncologyEurope PMC
  15. Cross-lineage anomaly detection of microRNA expression: a framework for deriving exploratory candidate biomarkers in sarcoma.
    Mritunjoy Dey, Piotr Remiszewski, Ewelina Perdas +3
    Frontiers in geneticsPeer-reviewedCC BYFull textOncologyEurope PMC
  16. Diagnostic accuracy of deep learning for microsatellite instability prediction in gastric cancer: A systematic review and meta-analysis
    Y. Du, H. Liao, J. Li +2
    medRxivPreprintCC BYFull textOncologymedRxiv
  17. Evaluate epidemiologic burden, treatment patterns and treatment outcomes of advanced prostate cancer in Hong Kong using territory-wide electronic medical records
    X. Li, Y. Jiao, J. Wang
    medRxivPreprintCC BY-NDFull textOncologymedRxiv
  18. MRI Biomarkers for Brain Metastases in Lung Cancer Using Machine Learning
    S. Chadha, D. V. Sritharan, R. Sharma +11
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  19. COVID-19 vaccination and survival of cancer patients in Northwestern Russia: a historical registry-based cohort study
    A. A. Dyachenko, M. A. Bogdanov, D. V. Bogdanov +5
    medRxivPreprintCC BYFull textOncologymedRxiv
  20. Cumulative burden of adverse childhood experiences (ACEs) and non-adherence to breast cancer screening: A dose-response and network intervention analysis
    Furong Chen, Jiaheng Shao, Jingjing Cai +5
    Translational PsychiatryPeer-reviewedCC BY 4.0Full textOncologyCrossref
  21. Transformer-Convolution Pyramid Network for Multi-Class Kidney, Tumor, and Cyst Segmentation
    Evgin Goceri
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  22. Complications of Percutaneous Thermal Ablation of Primary and Metastatic Lung Tumors: Review of Prevention and Management Strategies
    Guo Yuan How, Uei Pua
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  23. Genomic Determinants of Induction Failure and Persistent Prognostic Risk of FLT3-ITD in Pediatric Acute Myeloid Leukemia
    Rongqiu Liu, Yinghui Cui, Lan Huang +11
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  24. Cancer survival in Hebei Province, China (2009–2018): a population-based study
    Yanyu Liu, Daojuan Li, Siqi Wu +4
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0OncologyCrossref
  25. HeCOG Cancer Biobank and Registry: a nationwide real-world resource for translational oncology research.
    E Fountzilas, K Papadopoulou, G-A Koliou +34
    ESMO real world data and digital oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC